Insider Selling: Itron (NASDAQ:ITRI) SVP Sells $76,429.71 in Stock

Itron, Inc. (NASDAQ:ITRI) SVP Christopher Ware sold 763 shares of Itron stock in a transaction on Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $76,429.71. Following the completion of the transaction, the senior vice president owned 31,043 shares of the company’s stock, valued at approximately $3,109,577.31. This trade represents a 2.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Itron Price Performance

Itron stock opened at $97.15 on Thursday. The company has a current ratio of 1.80, a quick ratio of 1.56 and a debt-to-equity ratio of 0.45. Itron, Inc. has a 12-month low of $88.57 and a 12-month high of $142.00. The stock has a market cap of $4.37 billion, a P/E ratio of 14.92, a price-to-earnings-growth ratio of 0.85 and a beta of 1.48. The company has a fifty day simple moving average of $97.82 and a 200-day simple moving average of $109.44.

Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The firm had revenue of $571.66 million for the quarter, compared to analyst estimates of $561.31 million. During the same period last year, the business earned $1.35 EPS. Itron’s revenue for the quarter was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Equities analysts expect that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on ITRI shares. Guggenheim set a $155.00 target price on shares of Itron in a report on Friday, February 13th. Robert W. Baird set a $128.00 target price on Itron and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Johnson Rice raised shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price target on the stock in a research report on Monday, January 5th. Oppenheimer increased their target price on Itron from $125.00 to $133.00 and gave the company an “outperform” rating in a research note on Wednesday, February 18th. Finally, Argus reiterated a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Itron has an average rating of “Moderate Buy” and an average target price of $138.56.

Hedge Funds Weigh In On Itron

A number of hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Itron by 2.3% during the 3rd quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock valued at $731,809,000 after purchasing an additional 132,329 shares during the period. Impax Asset Management Group plc boosted its position in Itron by 127.3% in the third quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after buying an additional 890,040 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Itron by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock valued at $118,034,000 after purchasing an additional 194,768 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Itron by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock valued at $106,340,000 after buying an additional 6,598 shares during the last quarter. Finally, Handelsbanken Fonder AB grew its stake in shares of Itron by 6.0% during the third quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock valued at $124,545,000 after purchasing an additional 56,318 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.